News Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023 Continue Reading Previous Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPDNext Accenture Invests in Open Cosmos to Expand Access to Satellite Data Related Stories News Sunwave Health Achieves ONC Health IT Certification, Strengthening Its Commitment to Behavioral Health Providers News Google Cloud Announced as a Key Technology Partner for Odoo Connect 2025 in San Francisco News Walrus and Veea Inc. Announce Strategic Partnership to Unlock High-Performance Edge Utility for Decentralized Data Storage News CWE held ‘Lancang Mekong Green Course’ Open Day to celebrate the 10th anniversary of the Nam Ngiep 2 Hydropower Station News Ultraman Omega joins the battlefield alongside beloved Ultraman Arc in Tsuburaya Production’s new Starter Deck 03 ‘Ω to the Future’ and Booster Pack 4 ‘Gleam of Eternal Hope’ News Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China
